Art. 1 Decision_act (EU) 2003/2

In forcesince 21 Nov 2001cited 4×
1.

The following undertakings have infringed Article 81(1) of the Treaty and Article 53(1) of the EEA Agreement:

(a)

F. Hoffmann-La Roche AG by participating in agreements affecting the Community and EEA markets for vitamins A, E, B1, B2, B5, B6, C, D3, H, folic acid, beta-carotene and carotinoids;

(b)

BASF AG by participating in agreements affecting the Community and EEA markets for vitamins A, E, B1, B2, B5, C, D3, H, beta-carotene and carotinoids;

(c)

Aventis SA by participating in agreements affecting the Community and EEA markets for vitamins A, E, and D3;

(d)

Lonza AG by participating in agreements affecting the Community market for vitamin H;

(e)

Solvay Pharmaceuticals BV by participating in agreements affecting the Community and EEA markets for vitamin D3;

(f)

Merck KgaA by participating in agreements affecting the Community and EEA markets for vitamins C and H;

(g)

Daiichi Pharmaceutical Co. Ltd by participating in agreements affecting the Community and EEA markets for vitamins B5 and B6;

(h)

Eisai Co. Ltd by participating in agreements affecting the Community and EEA market for vitamin E;

(i)

Kongo Chemical Co. Ltd by participating in agreements affecting the Community market for folic acid;

(j)

Sumitomo Chemical Co. Ltd by participating in agreements affecting the Community market for vitamin H;

(k)

Sumika Fine Chemicals Ltd by participating in agreements affecting the Community market for folic acid;

(l)

Takeda Chemical Industries Ltd by participating in agreements affecting the Community and EEA markets for vitamins B1, B2, B6, C, and folic acid; and

(m)

Tanabe Seiyaku Co. Ltd by participating in agreements affecting the Community market for vitamin H.

2.

The duration of the infringements was as follows:

(a)

F. Hoffmann-La Roche AG, with respect to:

–

vitamin A: from September 1989 to February 1999,

–

vitamin E: from September 1989 to February 1999,

–

vitamin B1: from January 1991 to June 1994,

–

vitamin B2: from July 1991 to September 1995,

–

vitamin B5: from September 1991 to February 1999,

–

vitamin B6: from January 1991 to June 1994,

–

vitamin C: from January 1991 to August 1995,

–

vitamin D3: from January 1994 to June 1998,

–

vitamin H: from October 1991 to April 1994,

–

folic acid: from January 1991 to June 1994,

–

beta-carotene: from September 1992 to December 1998,

–

carotinoids: from May 1993 to December 1998;

(b)

BASF AG, with respect to:

–

vitamin A: from September 1989 to February 1999,

–

vitamin E: from September 1989 to February 1999,

–

vitamin B1: from January 1991 to June 1994,

–

vitamin B2: from July 1991 to September 1995,

–

vitamin B5: from September 1991 to February 1999,

–

vitamin C: from January 1991 to August 1995,

–

vitamin D3: from January 1994 to June 1998,

–

vitamin H: from October 1991 to April 1994,

–

beta-carotene: from September 1992 to December 1998,

–

carotinoids: from May 1993 to December 1998;

(c)

Aventis SA, with respect to:

–

vitamin A: from September 1989 to February 1999,

–

vitamin E: from September 1989 to February 1999,

–

vitamin D3: from January 1994 to July 1998;

(d)

Takeda Chemical Industries Ltd, with respect to:

–

vitamin B1: from January 1991 to June 1994,

–

vitamin B2: from January 1992 to September 1995,

–

vitamin B6: from January 1991 to June 1994,

–

vitamin C: from January 1991 to August 1995,

–

folic acid: from January 1991 to June 1994;

(e)

Merck KgaA, with respect to:

–

vitamin C: from January 1991 to August 1995,

–

vitamin H: from October 1991 to April 1994;

(f)

Daiichi Pharmaceutical Co. Ltd, with respect to:

–

vitamin B5: from September 1991 to February 1999,

–

vitamin B6: from January 1991 to June 1994;

(g)

Lonza AG, with respect to:

–

vitamin H: from October 1991 to April 1994;

(h)

Solvay Pharmaceuticals BV, with respect to:

–

vitamin D3: from January 1994 to June 1998;

(i)

Eisai Co. Ltd, with respect to:

–

vitamin E: from January 1991 to February 1999;

(j)

Kongo Chemical Co. Ltd, with respect to:

–

folic acid: from January 1991 to June 1994;

(k)

Sumitomo Chemical Co. Ltd, with respect to:

–

vitamin H: from October 1991 to April 1994;

(l)

Sumika Fine Chemicals Ltd, with respect to:

–

folic acid: from January 1991 to June 1994;

(m)

Tanabe Seiyaku Co. Ltd, with respect to:

–

vitamin H: from October 1991 to April 1994;

  • Judgment of the Court of First Instance (Fourth Chamber) of 15 March 2006. BASF AG v Commission of the European Communities.Decision

    Komise konstatovala v článku 1 rozhodnutí 2003/2/ES ze dne 21. listopadu 2001 v řízení podle článku 81 ES a článku 53 Dohody o EHP (věc COMP/E-1/37.512 - Vitaminy) (Úř. věst. 2003, L 6, s. 1, dále jen ‚Rozhodnutí‘), že …

    15 Mar 2006 · 62002TJ0015

  • Judgment of the Court of First Instance (Fourth Chamber, extended composition) of 6 October 2005. Sumitomo Chemical Co. Ltd and Sumika Fine Decision

    Komise konstatovala v článku 1 rozhodnutí 2003/2/ES ze dne 21. listopadu 2001 v řízení podle článku 81 ES a článku 53 Dohody o EHP (věc COMP/E-1/37.512 — Vitaminy) (Úř. věst. 2003, L 6, s. 1, dále jen „Rozhodnutí“), …

    6 Oct 2005 · 62002TJ0022

  • Judgment of the Court of First Instance (Fourth Chamber) of 15 March 2006. Daiichi Pharmaceutical Co. Ltd v Commission of the European CommuDecision

    Komise konstatovala v článku 1 rozhodnutí 2003/2/ES ze dne 21. listopadu 2001 v řízení podle článku 81 Smlouvy o založení ES a článku 53 Dohody o EHP (Věc COMP/E-1/37.512 — Vitaminy) (Úř. věst, L 6, s. 1, dále jen …

    15 Mar 2006 · 62002TJ0026

  • Order of the Court of First Instance (Fourth Chamber) of 25 February 2003. BASF AG v Commission of the European Communities.Decision

    By Decision 2003/2/EC of 21 November 2001 relating to a proceeding pursuant to Article 81 EC and Article 53 of the EEA Agreement (Case COMP/E-1/37.512 — Vitamins) (OJ 2003 L 6, p. 1, hereinafter ‘the Decision’), the Commission found …

    25 Feb 2003 · 62002TO0015